1 January 2001 in Neuroscience and Behavioral Physiology
19 September 2019 in Frontiers in Human Neuroscience
Word acquisition could be mediated by the neurocognitive mechanism known as fast mapping (FM). It refers to a process of incidental exclusion-based learning and is believed to be a critical mechanism for the rapid build-up of lexicon, although its neural mechanisms are still poorly understood. To investigate the neural bases of this key learning skill, we used event-related potentials (ERPs) and employed an audio-visual paradigm that included a counterbalanced set of familiar and novel spoken word forms presented, in a single exposure, in conjunction with novel and familiar images. To define learning-related brain dynamics, passive auditory ERPs, known to index long-term memory trace activation, were recorded before and after the FM task. Following the single FM learning exposure, we found a significant enhancement in neural activation elicited by the newly trained word form, which was expressed at ~200–400 ms after the word onset. No similar amplitude increase was found either for the native familiar word used as a control stimulus in the same learning paradigm or for similar control stimuli which were not subject to training. Topographic analysis suggested a left-lateral shift of the ERP scalp distribution for the novel FM word form, underpinned by fronto-temporal cortical sources, which may indicate the involvement of pre-existing neurolinguistic networks for mastering new word forms with native phonology. Overall, the near-instant changes in neural activity after a single-shot novel word training indicate that FM could promote rapid integration of newly learned items into the brain’s neural lexicon, even in adulthood.
1 May 2018 in Neurotoxicity Research
24 February 2012 in Neuroscience and Behavioral Physiology
15 October 2009 in Neuroscience and Behavioral Physiology
3 May 2019 in Frontiers in Pharmacology
The trace amine-associated receptor 1 (TAAR1) is a G protein-coupled receptor widely expressed in the mammalian brain, particularly in limbic system and monoaminergic areas. It has proven to be an important modulator of dopaminergic, serotoninergic, and glutamatergic neurotransmission and is considered to be a potential useful target for the pharmacotherapy of neuropsychiatric disorders, including schizophrenia. One of the promising schizophrenia endophenotypes is a deficit in neurocognitive abilities manifested as mismatch negativity (MMN) deficit. This study examines the effect of TAAR1 partial agonist RO5263397 on the MMN-like response in freely moving C57BL/6 mice. Event-related potentials (ERPs) were recorded from awake mice in the oddball paradigm before and after RO5263397 administration. The RO5263397 (but not saline) administration increased the N40 amplitude in response to deviant stimuli. That provided the MMN-like difference at the 36–44 ms interval after the injection. The pitch deviance-elicited changes before the injection and in the control paradigm were established for the P68 component. After TAAR1 agonist administration the P68 amplitude in response both to standard and deviant stimuli was increased. These results suggest that the MMN-like response in mice may be modulated through TAAR1-dependent processes (possibly acting through the direct or indirect glutamate NMDA receptor modulation), indicating the TAAR1 agonists potential antipsychotic and pro-cognitive activity.